GPT and cancer: Nevertheless, our findings provide a rationale for using ssTelo as a biomarker for ALT-positive cell detection, offering new avenues for studying and targeting ALT-driven cancers (Loe et al., 2020; Claude et al., 2021; Frank et al., 2022; Quintanilla et al., 2025).